13.07.2015 Views

Seroprevalence Survey of Chikungunya Virus in Bagan Panchor ...

Seroprevalence Survey of Chikungunya Virus in Bagan Panchor ...

Seroprevalence Survey of Chikungunya Virus in Bagan Panchor ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

1246 MAS AYU AND OTHERSFigure 1. Representation <strong>of</strong> <strong>Bagan</strong> <strong>Panchor</strong> village, which isarranged along a 1-km road runn<strong>in</strong>g from southeast to northwest adjacentto the <strong>Panchor</strong> River as it flows <strong>in</strong>to the Straits <strong>of</strong> Malacca. Thevillage is surrounded by a mangrove forest. The residences <strong>of</strong> seropositiveand seronegative residents with<strong>in</strong> areas A and B are shown.Seropositive cases were more likely to reside with<strong>in</strong> area B, which isalso where the shops and restaurants are located.with an equal volume <strong>of</strong> serum at 37°C for 1 hour. This antigen–serummixture was then added to the Vero cells <strong>in</strong> themicroplate and shaken for 1 hour. Excess suspension wasremoved, cells were briefly washed with serum-free media,and Eagle’s M<strong>in</strong>imum Essential Medium with 2% fetal bov<strong>in</strong>eserum (Thermo Fisher Scientific, Waltham, MA) was addedfor ma<strong>in</strong>tenance. The cells <strong>in</strong> the microplate were observedfor characteristic cytopathic effect. The neutralization titerfor a given serum sample was determ<strong>in</strong>ed by the highestdilution at which that serum neutralized the virus at day 7.Serum that conta<strong>in</strong>ed no neutraliz<strong>in</strong>g activity did not <strong>in</strong>hibitcytopathic effects and was considered to be seronegative.Serum with neutraliz<strong>in</strong>g activity was considered to be seropositive,<strong>in</strong>dicat<strong>in</strong>g laboratory-confirmed past CHIKV <strong>in</strong>fection.Each serum sample was tested <strong>in</strong> triplicate.Data were analyzed us<strong>in</strong>g SPSS 15.0 (SPSS Inc., Chicago,IL). Descriptive analysis was performed on demographic andsymptoms data. For univariate analysis, Mann-Whitney U testswere used for cont<strong>in</strong>uous variables, and χ 2 or Fisher’s exacttests were used for categorical variables. Logistic regressionanalyses were also carried out to determ<strong>in</strong>e demographic predictors<strong>of</strong> two separate outcomes: symptomatic disease andCHIKV seropositivity. Univariate logistic regression was <strong>in</strong>itiallycarried out for each variable. Those significant at P < 0.2were entered <strong>in</strong>to the multivariate regression model based onthe likelihood ratio test. F<strong>in</strong>al P values <strong>of</strong> < 0.05 were consideredas significant.RESULTSThere were about 150 houses <strong>in</strong> total <strong>in</strong> the village. A total<strong>of</strong> 180 residents, or 12% <strong>of</strong> the estimated 1,500 people, from80 houses agreed to be <strong>in</strong>terviewed ( Table 1 ) (mean age =38.2 years; range = 1–77 years). The 80 houses where the <strong>in</strong>terviewedparticipants lived were spread throughout the village;there was no difference between the percentages <strong>of</strong> housessampled <strong>in</strong> area A and area B (47.9% versus 58.2%; χ 2 = 1.6,P = 0.21). Of the 180 residents <strong>in</strong>terviewed, 72 (40.0%) agreedto have their serum tested (mean age = 44.0 years; range =12–77 years). Of the 72 people tested, 40 (55.6%) were seropositive,and 7 (17.5%) <strong>of</strong> these were asymptomatic. Of thetested acutely symptomatic participants, 33 <strong>of</strong> 38 (86.8%) wereseropositive; 7 <strong>of</strong> 34 (20.6%) tested asymptomatic participantswere seropositive. Three <strong>of</strong> seven asymptomatic seropositiveresidents had a symptomatic household member.Table 1Demographic characteristics <strong>of</strong> study participantsParticipants <strong>in</strong>terviewedParticipants tested for CHIKVTotal( N = 180)Asymptomatic( N = 109)Symptomatic( N = 71)Univariate analysis( P value)Total( N = 72)Seronegative( N = 32)Seropositive( N = 40)Univariate analysis( P value)Age (years)≤ 18 years 38 26 (68.4%) 12 (31.6%) 0.15 5 3 (60.0%) 2 (40.0%) 0.3219–49 years 79 49 (62.0%) 30 (38.0%) 0.33 39 19 (48.7%) 20 (51.3%) 0.29≥ 50 years 63 34 (54.0%) 29 (46.0%) Reference 28 10 (35.7%) 18 (64.3%) ReferenceSexMale 84 53 (63.1%) 31 (36.9%) Reference 38 20 (52.6%) 18 (47.4%) ReferenceFemale 96 56 (58.3%) 40 (41.7%) 0.52 34 12 (35.3%) 22 (64.7%) 0.14Residential areaA 82 62 (75.6%) 20 (24.4%) Reference 28 17 (60.7%) 11 (39.3%) ReferenceB 98 47 (48.0%) 51 (52.0%) < 0.001 * 44 15 (34.1%) 29 (65.9%) 0.03 †Education ‡Primary 77 43 (55.8%) 34 (44.2%) Reference 39 13 (33.3%) 26 (66.7%) ReferenceSecondary or tertiary 41 26 (63.4%) 15 (36.6%) 0.43 17 9 (52.9%) 8 (47.1%) 0.17Child ≤ 18 years 38 27 (71.1%) 11 (28.9%) 0.12 5 4 (80.0%) 1 (20.0%) 0.08No formal education 23 12 (52.2%) 11 (47.8%) 0.76 10 5 (50.0%) 5 (50.0%) 0.33Occupation ‡Housewife 56 31 (55.4%) 25 (44.6%) Reference 22 8 (36.4%) 14 (63.6%) ReferenceStudent 38 27 (71.1%) 11 (28.9%) 0.13 5 4 (80.0%) 1 (20.0%) 0.11Fisherman 24 13 (54.2%) 11 (45.8%) 0.92 16 7 (43.8%) 9 (56.3%) 0.65Unemployed 14 10 (71.4%) 4 (28.6%) 0.28 8 3 (37.5%) 5 (62.5%) 0.95Bus<strong>in</strong>essman 12 5 (41.7%) 7 (58.3%) 0.70 4 1 (25.0%) 3 (75.0%) 0.44Retired 10 7 (70.0%) 3 (30.0%) 0.39 4 3 (75.0%) 1 (25.0%) 0.66Other 25 15 (60.0%) 10 (40.0%) 0.39 12 6 (50.0%) 6 (50.0%) 0.18* Liv<strong>in</strong>g <strong>in</strong> area B was reta<strong>in</strong>ed <strong>in</strong> the f<strong>in</strong>al regression model as a predictor <strong>of</strong> be<strong>in</strong>g symptomatic (adjusted odds ratio = 3.4; 95% confidence <strong>in</strong>tervals = 1.8–6.4; P < 0.001).† Liv<strong>in</strong>g <strong>in</strong> area B was reta<strong>in</strong>ed <strong>in</strong> the f<strong>in</strong>al regression model as a predictor <strong>of</strong> be<strong>in</strong>g seropositive for CHIKV (adjusted odds ratio = 3.0; 95% confidence <strong>in</strong>tervals = 1.1–7.9; P = 0.029).‡ Data is miss<strong>in</strong>g for one patient.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!